Beijing Med-Pharm Corp. and Cytokine PharmaSciences, Inc. Reach Agreement to Distribute the Cervidil® Vaginal Insert Throughout the People's Republic of China

Plymouth Meeting, PA and King of Prussia, Pa, Aug. 29, 2005 - Beijing Med-Pharm Corporation (BJGP.PK) and Cytokine PharmaSciences, Inc. today announced they have reached a distribution agreement whereby Beijing Med-Pharm will be responsible for the distribution of Cytokine's Cervadil® vaginal insert in the People's Republic of China.

"We are pleased that Cytokine PharmaSciences has entrusted Cervadil to Beijing Med-Pharm," says Martyn D. Greenacre, Chairman of Beijing Med-Pharm.

"This underscores the faith that top U.S. Pharma Companies place in Beijing Med-Pharm to generate terrific results in China."

"China is one of the fastest growing pharmaceutical markets in the world," says Vidal de la Cruz, Ph.D., Vice President Business Development for Cytokine PharmaSciences.

"We are excited to reach this market and Beijing Med-Pharm is a top-tier partner to work with as we look to generate business there."

Cervadil is used to ripen the cervix in preparation for childbirth when labor is induced. It has been approved for use by the US. Food and Drug Administration and is marketed as Cervidil in North America, Australia, and New Zealand and as Propess® in most other parts of the world.

Beijing Med-Pharm expects the product to be marketed in the People's Republic of China as Propess.

For further information please contact

Beijing Med-Pharm
Ben Austin
+1 (917) 686 3979

Cytokine PharmaSciences
Dennis Willson
+1 (610) 687 1776

Amphion Innovations plc
Josh Berkman, Media Relations
+1 (646) 747 7158

About Beijing Med-Pharm
Beijing Med-Pharm Corporation is a pharmaceutical marketing company that offers the following services in China through its wholly-owned subsidiary, Beijing Med-Pharm Market Calculating Co. Ltd.: pre-market entry analysis; clinical trial management; product registration; market research; and pharmaceutical marketing to physicians, hospitals and other healthcare providers.

On the web:

About Cytokine PharmaSciences, Inc.
Cytokine PharmaSciences, Inc. is a successful biopharmaceutical company located in King of Prussia, Pennsylvania (near Philadelphia), USA. The company licenses technologies from academia and other sources, develops products from those technologies and outlicenses the products to third parties for marketing.

On the web:

About Amphion Innovations plc
Amphion Innovations plc recently listed on the AIM Exchange in London under the symbol AMP.L. Amphion's business is the formation, financing, management, and development of life science and technology companies, working in partnership with corporations, governments, universities, and entrepreneurs seeking to commercialize their intellectual property.

On the web: